NCT00714909

Unknown

Determination of Predictive Value of Echography Doppler Abno...

Assistance Publique - Hôpitaux de Paris Source

Compare

Other study identifiers

Sponsor study identifier

K070104

Study Type

observational

Estimated enrollment

600

Locations

1 country

Sites

1

Timeline

Study Start

November 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

November 2011

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

May 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

In order to avoid to use a traumatic and iatrogenic examen (phlebography), the purpose of the study is to validate echography doppler in the diagnosis of asymptomatic related catheter related thrombosis.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 600 participants
Study completion date: May 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
July 11, 2008
Actual (reported)
First Posted
July 14, 2008
Actual (reported)
Study Start
November 2008
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
November 2011
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: February 23, 2011
Status Verified: February 2011
Last Update Submitted: February 22, 2011

Conditions

Breast Cancer Upper Extremity Deep Vein Thrombosis, Secondary

Keywords

Breast cancerCatheter related thrombosisDiagnosisEchography dopplerRisk factors

Outcome Measures

Primary Outcomes (1)

Symptomatic catheter related thrombosis, as confirmed by echography doppler, phlebography or angiography scan
within 6 months

Study Arms (1)

1

Eligibility Criteria

Age18 Years - 80 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

All consecutive patients treated receiving adjuvant chemotherapy for localized breast cancer in the participating centers

You may qualify if:

women over 18

Sponsors & Collaborators

Assistance Publique - Hôpitaux de Paris
Otherlead

Study Sites (1)

Saint-Louis Hospital

Paris, 75010, France

RECRUITING

Philippe M Debourdeau, MDCONTACT+33 1 4249 9768 onco.debourdeau@yahoo.fr

Philippe M Debourdeau, MDPRINCIPAL INVESTIGATOR

MeSH Terms

Conditions

Breast NeoplasmsUpper Extremity Deep Vein ThrombosisDisease

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesVenous ThrombosisThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Philippe M Debourdeau, MD
Saint-Louis Hospital, Paris, France
PRINCIPAL INVESTIGATOR

Central Study Contacts

Philippe M Debourdeau, MD

CONTACT

+33 1 4249 9768 onco.debourdeau@yahoo.fr

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER

Study Record Dates

First Submitted

July 11, 2008

First Posted

July 14, 2008

Study Start

November 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

November 2011

Estimated (date passed)

NCT00949598

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

Phase 3Completed

NCT00717405

A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.

Phase 2Completed

NCT00953537

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

Not ApplicableCompleted

NCT00820547

Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients

Phase 2Completed

NCT01180335

Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer

Phase 3Completed

NCT01436591

Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors

Terminated

histologically proven breast cancer

localized breast cancer without metastasis

adjuvant or neo adjuvant chemotherapy

insertion of central catheter with port for chemotherapy

central catheter for more than three months

inform consent

follow up for three months

You may not qualify if:

ongoing anticoagulant therapy
previous central catheter
femoral catheter
double lumen catheter
central catheter without port
platelets \< 80G/L, TQ \< 50%, fibrinogen \< 1 g/L
creatinin \> 175mole/L

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

May 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

February 23, 2011

Record last verified: 2011-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00714909
Data provider: ClinicalTrials.gov
Source updated: 2011-02-23
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:06 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

1

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations